Status:
NOT_YET_RECRUITING
Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension
Lead Sponsor:
The Cleveland Clinic
Conditions:
Hypertension
Hypertension (HTN)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to study whether having a clinical decision support (CDS) tool available to clinician use will more effectively lower BP 4 weeks after an outpatient visit compared w...
Eligibility Criteria
Inclusion
- Men and women 18 years of age or older
- Electronic Health Record (EHR) of hypertension AND prescribed at least one BP lowering medication
- Office systolic BP of 130 mmHg or higher
- Willing and able to comply with the study instructions AND attend a scheduled study visit
Exclusion
- Women who are pregnant, plan to become pregnant, or are breast-feeding
- Know heart failure with reduced ejection fraction and a left ventricular ejection fraction of less than 40%
- End-stage kidney disease currently undergoing renal replacement therapy, or an eGFR \< 15ml/min/1.73m2
- In the opinion of the investigator, any other condition that will preclude participation in the study
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT07218198
Start Date
December 1 2025
End Date
June 1 2027
Last Update
October 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195